New roles for the femtosecond discussed. Subretinal implant disappoints. Genentech defends its actions relating to Avastin decision. Glaucoma pipeline looks very healthy, and much more.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.